Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (CTRI/2026/09/117349) titled 'A Study Comparing Two Medicines, Lumateperone and Olanzapine, in People Experiencing Schizophrenia for the First Time' on Sept. 9.
Study Type: Interventional
Study Design:
Randomized, Parallel Group, Active Controlled Trial Method of generating randomization sequence:Computer generated randomization Method of allocation concealment:Alternation Blinding and masking:Participant and Outcome Assessor Blinded
Primary Sponsor: Central Institute of Psychiatry
Condition:
Health Condition 1: F203- Undifferentiated schizophrenia
Health Condition 2: F200- Paranoid schizophrenia
Health Condition 3: F201- Disorga...